Article info

Download PDFPDF
The PTPN22 susceptibility risk variant is not associated with the rate of joint destruction in anti-citrullinated protein antibody-positive rheumatoid arthritis
  1. Correspondence to Dr R Knevel, Department of Rheumatology, Leiden University Medical Center, Albinusdreef 2, Leiden 2300, The Netherlands, r.knevel{at}lumc.nl
View Full Text

Citation

van Nies JAB, Knevel R, Daha N, et al
The PTPN22 susceptibility risk variant is not associated with the rate of joint destruction in anti-citrullinated protein antibody-positive rheumatoid arthritis

Publication history

  • Accepted December 3, 2009
  • First published April 13, 2010.
Online issue publication 
April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.